Less Invasive Left Ventricular Assist Device Implantation Is Safe and Reduces Intraoperative Blood Product Use: A Propensity Score Analysis VAD Implantation Techniques and Blood Product Use.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
pubmed:
15
5
2020
medline:
27
4
2021
entrez:
15
5
2020
Statut:
ppublish
Résumé
Despite increasing popularity and multiple postulated benefits, less invasive (LIS) left ventricular assist device (LVAD) implantation has not been sufficiently compared with standard full sternotomy (FS). We report the outcomes of a propensity score analysis designed to compare LIS and FS LVAD implantation, with perioperative blood product use, adverse event rates, and mortality as primary objective. From September 2010 to August 2016, 159 consecutive patients received a Medtronic HVAD or Abbott HeartMate 3 LVAD via a FS or LIS approach. Outcomes were analyzed using proportional hazard Cox regression, with risk adjustment based on a LIS approach propensity score model computed from demographics, risk factors, and operative covariates. Seventy-five patients were matched and compared (HVAD 83% [n = 62]; LIS approach 43% [n = 32]; mean age 60 ± 12 years; 89% [n = 67] male; 48% [n = 36] ischemic cardiomyopathy [ICMP]; 37% [n = 28]). Patient groups were comparable with regard to preoperative patient characteristics. Less invasive LVAD implantation was successful in all patients with no intraoperative conversions. In-hospital mortality was 16% in both groups, despite 37% Interagency Registry for Mechanically Assisted Circulatory Support Level I patients. Overall, 28% of the LIS patients did not receive any blood products intraoperatively, whereas, in the FS group, only two patients (5%) did not require the administration of blood products (p = 0.000). This was also a significant finding in the overall perioperative phase in which seven LIS patients (22%) who not receive any blood products versus two FS patients (5%; p = 0.033). Otherwise, outcomes were comparable. Less invasive LVAD implantation is a feasible, safe, and reduces blood product use.
Identifiants
pubmed: 32404616
pii: 00002480-202101000-00011
doi: 10.1097/MAT.0000000000001165
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-52Informations de copyright
Copyright © 2020 by the ASAIO.
Références
Ponikowski P, Voors AA, Anker SD, et al.; ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37:2129–2200
Kirklin JK, Naftel DC, Pagani FD, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015; 34:1495–1504
Hashemi N, Johnson J, Brodin LÅ, et al. Right ventricular mechanics and contractility after aortic valve replacement surgery: A randomised study comparing minimally invasive versus conventional approach. Open Heart. 2018; 5:e000842
Downs EA, Johnston LE, LaPar DJ, et al. Minimally invasive mitral valve surgery provides excellent outcomes without increased cost: A multi-institutional analysis. Ann Thorac Surg. 2016; 102:14–21
Ghanta RK, Lapar DJ, Kern JA, et al. Minimally invasive aortic valve replacement provides equivalent outcomes at reduced cost compared with conventional aortic valve replacement: A real-world multi-institutional analysis. J Thorac Cardiovasc Surg. 2015; 149:1060–1065
Schechter MA, Patel CB, Blue LJ, et al. Improved early survival with a nonsternotomy approach for continuous-flow left ventricular assist device replacement. Ann Thorac Surg. 2015; 99:561–566
Haberl T, Riebandt J, Mahr S, et al. Viennese approach to minimize the invasiveness of ventricular assist device implantation. Eur J Cardiothorac Surg. 2014; 46:991–996
Sileshi B, Haglund NA, Davis ME, et al. In-hospital outcomes of a minimally invasive off-pump left thoracotomy approach using a centrifugal continuous-flow left ventricular assist device. J Heart Lung Transplant. 2015; 34:107–112
Sileshi B, O’Hara BK, Davis ME, et al. Outcomes of patients implanted using a left thoracotomy technique for a miniaturized centrifugal continuous-flow pump. ASAIO J. 2016; 62:539–544
Maltais S, Davis ME, Haglund N. Minimally invasive and alternative approaches for long-term LVAD placement: The Vanderbilt strategy. Ann Cardiothorac Surg. 2014; 3:563–569
Slaughter MS. Implantation of the HeartWare left ventricular assist device. Semin Thorac Cardiovasc Surg. 2011; 23:245–247
Netuka I, Sood P, Pya Y, et al. Fully magnetically levitated left ventricular assist system for treating advanced HF: A multicenter study. J Am Coll Cardiol. 2015; 66:2579–2589
Cheung A, Lamarche Y, Kaan A, et al. Off-pump implantation of the HeartWare HVAD left ventricular assist device through minimally invasive incisions. Ann Thorac Surg. 2011; 91:1294–1296
Wieselthaler GM, O Driscoll G, Jansz P, Khaghani A, Strueber M. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant. 2010; 29:1218–1225
Riebandt J, Wiedemann D, Laufer G, Zimpfer D. Sternotomy sparing Thoratec HeartMate 3 implantation via bilateral minithoracotomy. Innovations (Phila). 2018; 13:74–76
Blackstone EH. Comparing apples and oranges. J Thorac Cardiovasc Surg. 2002; 123:8–15
Maltais S, Anwer LA, Tchantchaleishvili V, et al. Left lateral thoracotomy for centrifugal continuous-flow left ventricular assist device placement: An analysis from the mechanical circulatory support research network. ASAIO J. 2018; 64:715–720
Ferraris VA, Ballert EQ, Mahan A. The relationship between intraoperative blood transfusion and postoperative systemic inflammatory response syndrome. Am J Surg. 2013; 205:457–465
Lemaignen A, Birgand G, Ghodhbane W, et al. Sternal wound infection after cardiac surgery: Incidence and risk factors according to clinical presentation. Clin Microbiol Infect. 2015; 21:674.e11–674.e18
Muslem R, Caliskan K, van Thiel R, et al. Incidence, predictors and clinical outcome of early bleeding events in patients undergoing a left ventricular assist device implant. Eur J Cardiothorac Surg. 2018; 54:176–182
Maltais S, Davis ME, Haglund NA, et al. Active clearance of chest tubes reduces re-exploration for bleeding after ventricular assist device implantation. ASAIO J. 2016; 62:704–709
Unsworth B, Casula RP, Kyriacou AA, et al. The right ventricular annular velocity reduction caused by coronary artery bypass graft surgery occurs at the moment of pericardial incision. Am Heart J. 2010; 159:314–322
Dell’Italia LJ. Anatomy and physiology of the right ventricle. Cardiol Clin. 2012; 30:167–187